Correction: Characteristics of Late-Onset Spondyloarthritis: Data from the Moroccan Registry of Biological Therapies in Rheumatic Diseases (2023)
https://pubmed.ncbi.nlm.nih.gov/37273404/

Characteristics of Late-Onset Spondyloarthritis: Data from the Moroccan Registry of Biological Therapies in Rheumatic Diseases (2023)
https://pubmed.ncbi.nlm.nih.gov/37273389/

Recommendations of the Moroccan Society of Rheumatology (SMR) for the Therapeutic Management of Spondyloarthritis (SpA) including Psoriatic Arthritis (PsA) (2023)
https://pubmed.ncbi.nlm.nih.gov/37654637/

Determinants of health-related quality of life in spondyloarthritis and rheumatoid arthritis – data from the COMOSPA and COMORA studies (2022)
https://pubmed.ncbi.nlm.nih.gov/36115216/

Extra-Articular Manifestations in Patients with Ankylosing Spondylitis: Baseline Characteristics from the RBSMR Study (2022)
https://pubmed.ncbi.nlm.nih.gov/36531422/

Discontinuation of biologic therapy in patients with rheumatoid arthritis and ankylosing spondylitis: analysis from multicenter cohort study (2022)
https://pubmed.ncbi.nlm.nih.gov/36334121/

Utilisation des AINS et des antalgiques chez les patients ayant une spondyloarthrite sous biothérapie. Données du registre de biothérapie de la Société Marocaine de rhumatologie (RBSMR) (2020)
https://doi.org/10.1016/j.rhum.2020.07.003

The Prevalence of the Coxitis in Patients with Spondyloarthritis and its Relation with the Disease Features: RBSMR Study (2020)
https://doi.org/10.1111/1756-185X.13013

Radiographic axial versus nonradiographic axial spondyloarthritis: Comparison of the disease activity parameters and the disease activity and functional scores: RBSMR study (2019)
https://www.openaccessjournals.com/abstract/radiographic-axial-versus-nonradiographic-axial-spondyloarthritis-comparison-of-the-disease-activity-parameters-and-the--13109.html

Vitamin D, disease activity and comorbidities in early spondyloarthritis (2016)
https://pubmed.ncbi.nlm.nih.gov/27050724/

Early increase of abdominal adiposity in patients with spondyloarthritis receiving anti-tumor necrosis factor-α treatment. (2014)
https://pubmed.ncbi.nlm.nih.gov/24737911/

The relation between disease activity, vitamin D levels and bone mineral density in men patients with ankylosing spondylitis (2013)
https://doi.org/10.4081/rr.2013.e3

Normative values for the Bath Ankylosing Spondylitis Functional Index in the general population compared with ankylosing spondylitis patients in Morocco (2012)
https://doi.org/10.1186/1471-2474-13-40

Evaluation and stability of the Patient Acceptable Symptom State (PASS) over time in patients with ankylosing spondylitis. (2012)
https://www.ncbi.nlm.nih.gov/pubmed/22260741